COVID-19: consider cytokine storm syndromes and immunosuppression

Lancet. 2020 Mar 28;395(10229):1033-1034. doi: 10.1016/S0140-6736(20)30628-0. Epub 2020 Mar 16.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antirheumatic Agents / therapeutic use
  • Betacoronavirus / immunology*
  • COVID-19
  • COVID-19 Drug Treatment
  • COVID-19 Serotherapy
  • Coronavirus Infections / complications*
  • Coronavirus Infections / drug therapy
  • Coronavirus Infections / immunology
  • Coronavirus Infections / therapy
  • Cytokines / metabolism*
  • Humans
  • Immunization, Passive
  • Immunoglobulins, Intravenous / therapeutic use
  • Immunosuppression Therapy / methods*
  • Immunosuppressive Agents
  • Inflammation / drug therapy*
  • Inflammation / etiology
  • Pandemics
  • Pneumonia, Viral / complications*
  • Pneumonia, Viral / drug therapy
  • Pneumonia, Viral / immunology
  • SARS-CoV-2
  • Steroids / therapeutic use

Substances

  • Antirheumatic Agents
  • Cytokines
  • Immunoglobulins, Intravenous
  • Immunosuppressive Agents
  • Steroids